Literature DB >> 9134973

Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations.

A Williams1, A M Van Dam, D Ritchie, P Eikelenboom, H Fraser.   

Abstract

The appearance of immunoreactive interleukin (IL)-1beta, IL-6 and tumour necrosis factor (TNF)-alpha, prostaglandin (PG) E2 and lipocortin-1 in the central nervous system was investigated during the development of lesions in a 301V/VM murine scrapie model. Focal PrP(Sc) deposition was present after 30 days of the 115-120 day incubation period; this immunoreactivity increased in intensity and distribution thereafter. Staining for IL-1beta and TNF alpha in perivascular macrophages, and PGE2 immunoreactivity in astrocytes, was detected in those areas showing PrP(Sc) deposition from 60 days. Increased GFAP and F4/80 immunoreactivity, indicating activation of astrocytes and microglia, was also evident in these areas from 60 days. Glial cytokine and lipocortin immunoreactivity was detected after 90 days, in the absence of clinical signs. The disease-induced cytokine, PG and lipocortin immunoreactivity occurred only in those brain areas showing PrP(Sc) deposition, glial activation and, in later stages, vacuolation. These findings support the concept that PrP(Sc) deposition induces glial cytokine production. These glial cytokines may contribute to the development of the pathological lesions in scrapie.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9134973     DOI: 10.1016/s0006-8993(97)00067-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  34 in total

1.  Identification of upregulated genes in scrapie-infected brain tissue.

Authors:  C Riemer; I Queck; D Simon; R Kurth; M Baier
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Brain infection by neuroinvasive but avirulent murine oncornaviruses.

Authors:  S Asković; F J McAtee; C Favara; J L Portis
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Tumor necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie.

Authors:  N A Mabbott; A Williams; C F Farquhar; M Pasparakis; G Kollias; M E Bruce
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  IL-1 family members as candidate genes modulating scrapie susceptibility in sheep: localization, partial characterization, and expression.

Authors:  Ane Marcos-Carcavilla; Jorge H Calvo; Carmen González; Katayoun Moazami-Goudarzi; Pascal Laurent; Maud Bertaud; Hélène Hayes; Anne E Beattie; Carmen Serrano; Jaber Lyahyai; Inmaculada Martín-Burriel; Estefânia Alves; Pilar Zaragoza; Juan J Badiola; Magdalena Serrano
Journal:  Mamm Genome       Date:  2007-01-22       Impact factor: 2.957

5.  PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.

Authors:  Mathéa Pietri; Caroline Dakowski; Samia Hannaoui; Aurélie Alleaume-Butaux; Julia Hernandez-Rapp; Audrey Ragagnin; Sophie Mouillet-Richard; Stéphane Haik; Yannick Bailly; Jean-Michel Peyrin; Jean-Marie Launay; Odile Kellermann; Benoit Schneider
Journal:  Nat Med       Date:  2013-08-18       Impact factor: 53.440

6.  Abnormal activation of microglia accompanied with disrupted CX3CR1/CX3CL1 pathway in the brains of the hamsters infected with scrapie agent 263K.

Authors:  Wu-Ling Xie; Qi Shi; Jin Zhang; Bao-Yun Zhang; Han-Shi Gong; Yan Guo; Shao-Bin Wang; Yin Xu; Ke Wang; Cao Chen; Yong Liu; Xiao-Ping Dong
Journal:  J Mol Neurosci       Date:  2013-03-24       Impact factor: 3.444

7.  Phospholipase A2 inhibitors protect against prion and Abeta mediated synapse degeneration.

Authors:  Clive Bate; Mourad Tayebi; Alun Williams
Journal:  Mol Neurodegener       Date:  2010-04-08       Impact factor: 14.195

8.  Role of interleukin-1 in prion disease-associated astrocyte activation.

Authors:  Julia Schultz; Anja Schwarz; Sabine Neidhold; Michael Burwinkel; Constanze Riemer; Dietrich Simon; Manfred Kopf; Markus Otto; Michael Baier
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

9.  Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels.

Authors:  Déborah Tribouillard-Tanvier; James F Striebel; Karin E Peterson; Bruce Chesebro
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

10.  Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines.

Authors:  Clive Bate; Mourad Tayebi; Luisa Diomede; Mario Salmona; Alun Williams
Journal:  PLoS One       Date:  2009-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.